According to an announcement made by GI Dynamics Inc., new data results demonstrate that the EndoBarrier®, a new device for the treatment of type 2 diabetes and/or obesity, is feasible and can be re-implanted safely. EndoBarrier is a pioneering device for the treatment of type 2 diabetes and/or...